SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000902664-22-003257
Filing Date
2022-06-10
Accepted
2022-06-10 16:15:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 ACORDA THERAPEUTICS, INC. p22-1641sc13d.htm SC 13D 148984
  Complete submission text file 0000902664-22-003257.txt   150549
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81801 | Film No.: 221009052
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 520 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022
Business Address 520 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022 212-446-4000
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by) CIK: 0001595082 (see all company filings)

IRS No.: 133863161 | State of Incorp.: DE
Type: SC 13D